ETV4 and hepatocellular carcinoma: Furthermore, HBx increases the expression of ETS variant 4 (ETV4) through Disheveled 2 (DVL2) transcriptional activation and consequent inhibition of β-catenin degradation; this Wnt deregulation is associated with HCC progression and poor prognosis [58].